SOC Drugs

# 1. Target: GSR

Drugs

Model Evidence

6 regulons containing the target(s), GSR are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

Glioblastoma Clinical Trials

Network Plots


Drugs in GBM Trials

# 1. Target: FNTA,FNTB

Drugs

Model Evidence

15 regulons containing the target(s), FNTA,FNTB are overactive in this patient.

Hallmarks Enrichment

HALLMARK_OXIDATIVE_PHOSPHORYLATION

Literature Evidence

Glioblastoma Clinical Trials

Network Plots


2. Target: ALDH2

Drugs

Model Evidence

2 regulons containing the target(s), ALDH2 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

Network Plots


3. Target: JAK1,JAK2

Drugs

Model Evidence

24 regulons containing the target(s), JAK1,JAK2 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

Network Plots


FDA Approved Drugs

# 1. Target: KCNK3

Drugs

Model Evidence

2 regulons containing the target(s), KCNK3 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


2. Target: SLC6A1

Drugs

Model Evidence

3 regulons containing the target(s), SLC6A1 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


3. Target: ADORA1

Drugs

Model Evidence

4 regulons containing the target(s), ADORA1 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


4. Target: JAK2

Drugs

Model Evidence

20 regulons containing the target(s), JAK2 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


5. Target: JAK1

Drugs

Model Evidence

4 regulons containing the target(s), JAK1 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


6. Target: ABL1

Drugs

Model Evidence

5 regulons containing the target(s), ABL1 are overactive in this patient.

Literature Evidence

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


7. Target: JAK1,JAK2

Drugs

Model Evidence

24 regulons containing the target(s), JAK1,JAK2 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


8. Target: RTN4

Drugs

Model Evidence

3 regulons containing the target(s), RTN4 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


9. Target: FNTA,FNTB

Drugs

Model Evidence

15 regulons containing the target(s), FNTA,FNTB are overactive in this patient.

Hallmarks Enrichment

HALLMARK_OXIDATIVE_PHOSPHORYLATION

Literature Evidence

Glioblastoma Clinical Trials

Network Plots


10. Target: MAPK1,MAPK3

Drugs

Model Evidence

20 regulons containing the target(s), MAPK1,MAPK3 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

Network Plots


11. Target: BACE1

Drugs

Model Evidence

1 regulons containing the target(s), BACE1 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


12. Target: NDUFA13

Drugs

Model Evidence

5 regulons containing the target(s), NDUFA13 are overactive in this patient.

Literature Evidence

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


13. Target: TSG101

Drugs

Model Evidence

2 regulons containing the target(s), TSG101 are overactive in this patient.

Literature Evidence

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


14. Target: VAMP2

Drugs

Model Evidence

2 regulons containing the target(s), VAMP2 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


15. Target: NQO1

Drugs

Model Evidence

2 regulons containing the target(s), NQO1 are overactive in this patient.

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


16. Target: TRPV4

Drugs

Model Evidence

1 regulons containing the target(s), TRPV4 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


17. Target: HSPA8

Drugs

Model Evidence

29 regulons containing the target(s), HSPA8 are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


18. Target: ABAT

Drugs

Model Evidence

16 regulons containing the target(s), ABAT are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


19. Target: GSR

Drugs

Model Evidence

6 regulons containing the target(s), GSR are overactive in this patient.

Hallmarks Enrichment

None

Literature Evidence

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


20. Target: ATP1A1

Drugs

Model Evidence

63 regulons containing the target(s), ATP1A1 are overactive in this patient.

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


21. Target: SOD1

Drugs

Model Evidence

5 regulons containing the target(s), SOD1 are overactive in this patient.

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots


22. Target: ACVR2B

Drugs

Model Evidence

5 regulons containing the target(s), ACVR2B are overactive in this patient.

Literature Evidence

No additional evidence was found

Glioblastoma Clinical Trials

No glioblastoma clinical trials were found for these drugs.

Network Plots

***Warning message: Missing column names filled in: ‘X15’ [15], ‘X16’ [16], ‘X17’ [17], ‘X18’ [18], ‘X19’ [19], ‘X20’ [20], ‘X21’ [21], ‘X22’ [22], ‘X23’ [23], ‘X24’ [24], ‘X25’ [25], ‘X26’ [26], ‘X27’ [27], ‘X28’ [28], ‘X29’ [29], ‘X30’ [30], ‘X31’ [31], ‘X32’ [32], ‘X33’ [33], ‘X34’ [34], ‘X35’ [35], ‘X36’ [36], ‘X37’ [37], ‘X38’ [38], ‘X39’ [39], ‘X40’ [40], ‘X41’ [41], ‘X42’ [42], ‘X43’ [43], ‘X44’ [44], ‘X45’ [45], ‘X46’ [46], ‘X47’ [47], ‘X48’ [48], ‘X49’ [49], ‘X50’ [50], ‘X51’ [51], ‘X52’ [52], ‘X53’ [53], ‘X54’ [54], ‘X55’ [55], ‘X56’ [56], ‘X57’ [57], ‘X58’ [58], ‘X59’ [59], ‘X60’ [60], ‘X61’ [61], ‘X62’ [62], ‘X63’ [63], ‘X64’ [64], ‘X65’ [65], ‘X66’ [66], ‘X67’ [67], ‘X68’ [68], ‘X69’ [69], ‘X70’ [70], ‘X71’ [71], ‘X72’ [72], ‘X73’ [73], ‘X74’ [74], ‘X75’ [75], ‘X76’ [76], ‘X77’ [77], ‘X78’ [78], ‘X79’ [79], ‘X80’ [80], ‘X81’ [81], ‘X82’ [82], ‘X83’ [83], ‘X84’ [84], ‘X85’ [85], ‘X86’ [86], ‘X87’ [87], ‘X88’ [88], ‘X89’ [89], ‘X90’ [90], ‘X91’ [91], ‘X92’ [92], ‘X93’ [93], ‘X94’ [94], ‘X95’ [9 [… truncated]